ubmslateCN-logo-ubm

CN Mobile Logo

Search form

Topics:

New Developments in Active Surveillance for Prostate Cancer

New Developments in Active Surveillance for Prostate Cancer

At the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting, held June 3–7 in Chicago, Stacy Loeb, MD, of the NYU Langone Medical Center in New York, New York, and Peter L. Choyke, MD, of the National Cancer Institute in Bethesda, Maryland, gave presentations during the education session “Contemporary Active Surveillance for Prostate Cancer: Do We Need Better Imaging and Molecular Testing?”

In this peer-to-peer discussion, Dr. Loeb and Dr. Choyke discuss some of the salient points from their session, including the use of magnetic resonance imaging for patient selection and follow-up and the use of new molecular markers that could signal tumor changes in patients on surveillance.

 
Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.